BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20682565)

  • 1. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval.
    den Heijer CD; Donker GA; Maes J; Stobberingh EE
    J Antimicrob Chemother; 2010 Oct; 65(10):2128-33. PubMed ID: 20682565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County.
    Lindbäck H; Lindbäck J; Sylvan S; Melhus A
    Scand J Infect Dis; 2010 Apr; 42(4):243-8. PubMed ID: 20085420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance pattern of uropathogenic Escherichia coli in South West Nigeria.
    Okesola AO; Aroundegbe TI
    Afr J Med Med Sci; 2011 Sep; 40(3):235-8. PubMed ID: 22428518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
    Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting.
    Kronenberg A; Koenig S; Droz S; Mühlemann K
    Clin Microbiol Infect; 2011 Dec; 17(12):1845-51. PubMed ID: 21880098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].
    El Bouamri MC; Arsalane L; Kamouni Y; Yahyaoui H; Bennouar N; Berraha M; Zouhair S
    Prog Urol; 2014 Dec; 24(16):1058-62. PubMed ID: 25310915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.
    Oteo J; Bautista V; Lara N; Cuevas O; Arroyo M; Fernández S; Lázaro E; de Abajo FJ; Campos J;
    J Antimicrob Chemother; 2010 Nov; 65(11):2459-63. PubMed ID: 20851815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance patterns and sequencing of class I integron from uropathogenic Escherichia coli in Lebanon.
    El-Najjar NG; Farah MJ; Hashwa FA; Tokajian ST
    Lett Appl Microbiol; 2010 Oct; 51(4):456-61. PubMed ID: 20840552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
    Nys S; Terporten PH; Hoogkamp-Korstanje JA; Stobberingh EE;
    J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval.
    De Backer D; Christiaens T; Heytens S; De Sutter A; Stobberingh EE; Verschraegen G
    J Antimicrob Chemother; 2008 Aug; 62(2):364-8. PubMed ID: 18499768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.
    Vellinga A; Murphy AW; Hanahoe B; Bennett K; Cormican M
    J Antimicrob Chemother; 2010 Jul; 65(7):1514-20. PubMed ID: 20457673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture.
    Nys S; van Merode T; Bartelds AI; Stobberingh EE
    J Antimicrob Chemother; 2006 May; 57(5):955-8. PubMed ID: 16554337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008.
    Qi C; Pilla V; Yu JH; Reed K
    Diagn Microbiol Infect Dis; 2010 May; 67(1):87-91. PubMed ID: 20227224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of virulence factors of uropathogenic Escherichia coli and its antibiotic susceptibility pattern.
    Mittal S; Sharma M; Chaudhary U
    Indian J Pathol Microbiol; 2014; 57(1):61-4. PubMed ID: 24739833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.